The field of urologic oncology is experiencing rapid advancements in recent years, fueled by breakthroughs in diagnosis, treatment, and patient care. Cutting-edge therapeutic approaches such as targeted therapy and immunotherapy are altering the landscape of urologic cancer treatment. Additionally, advancements in imaging techniques enable earlier